Skip to main content
Premium Trial:

Request an Annual Quote

GeneMachines Licenses Microarray Printing Technology from Incyte

NEW YORK, July 23 – GeneMachines has licensed two patents covering microarray fabrication technology from Incyte Genomics, the company said Monday.

The license will allow GeneMachines, based in San Carlos, Calif., to sell its microarray printing machines, the OmniGrid and OmniGrid Accent, with label licenses for research use. In a statement, the company made no mention of any changes to their microarraying products, which have been available to customers for several years.

Financial details were not disclosed.

The patents cover basic contact microarray printing technology for arraying DNA microarrays on solid substrates, GeneMachines said.

“We are excited to have worldwide licensing rights to this enabling technology which has become invaluable to genomics research," Scott Hunicke-Smith, CEO of GeneMachines, said in a statement.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.